Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ultragenyx
Sort By
Newest First
1 / 1
1 / 1
Clinical Data
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical, Inc.
PR-M09-19-NI-020
Sep 09, 2019
Partnership
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
GeneTx Biotherapeutics
PR-M08-19-NI-052
Aug 19, 2019
Licensing Agreement
REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
REGENXBIO
PR-M10-18-NI-093
Oct 26, 2018
Fill & Finish
Rentschler Fill Solutions and Ultragenyx Start Fill & Finish Collaboration for the US Commercial Supply of Drug Product Mepsevii
Rentschler Fill Solutions GmbH
PR-M06-18-NI-010
Jun 04, 2018
